A case of virchow's lymph node recurrence of gastric cancer who had underwent gastrectomy, and treated with S-1 monotherapy leading to complete response (CR)

Shinichi Tanaka, Kensaku Sanefuji, Akira Kabashima, Souichirou Maekawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We report the case of a 67-year-old male with Virchow's lymph node recurrence of gastric cancer, who underwent distal gastrectomy for type 2 forecourt part of pylorus gastric cancer, showing complete response (CR) in response to S-1 monotherapy. The tumor was pathologically diagnosed as Stage IIIb (well to poorly differentiated adenocarcinoma, T3 [SE], N2 [20/51], MO). Virchow's lymph node metastasis was confirmed 2 months after surgery. One week after S-1 administration, a reduction in lymph node size was observed. After 5 courses of S-1 monotherapy, he achieved CR. The patient maintained CR for 2 years, before we switched to uracil and tegaf ur (UFT) monotherapy. The patient maintained CR for 2 years, after which UFT was discontinued. No relapse was observed 22 months after discontinuation.

Original languageEnglish
Pages (from-to)455-457
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume43
Issue number4
Publication statusPublished - Apr 1 2016
Externally publishedYes

Fingerprint

Gastrectomy
Stomach Neoplasms
Lymph Nodes
Recurrence
Uracil
Pylorus
Adenocarcinoma
Neoplasm Metastasis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

A case of virchow's lymph node recurrence of gastric cancer who had underwent gastrectomy, and treated with S-1 monotherapy leading to complete response (CR). / Tanaka, Shinichi; Sanefuji, Kensaku; Kabashima, Akira; Maekawa, Souichirou.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 43, No. 4, 01.04.2016, p. 455-457.

Research output: Contribution to journalArticle

@article{8874ddd041634735b05ca5921dc17b0b,
title = "A case of virchow's lymph node recurrence of gastric cancer who had underwent gastrectomy, and treated with S-1 monotherapy leading to complete response (CR)",
abstract = "We report the case of a 67-year-old male with Virchow's lymph node recurrence of gastric cancer, who underwent distal gastrectomy for type 2 forecourt part of pylorus gastric cancer, showing complete response (CR) in response to S-1 monotherapy. The tumor was pathologically diagnosed as Stage IIIb (well to poorly differentiated adenocarcinoma, T3 [SE], N2 [20/51], MO). Virchow's lymph node metastasis was confirmed 2 months after surgery. One week after S-1 administration, a reduction in lymph node size was observed. After 5 courses of S-1 monotherapy, he achieved CR. The patient maintained CR for 2 years, before we switched to uracil and tegaf ur (UFT) monotherapy. The patient maintained CR for 2 years, after which UFT was discontinued. No relapse was observed 22 months after discontinuation.",
author = "Shinichi Tanaka and Kensaku Sanefuji and Akira Kabashima and Souichirou Maekawa",
year = "2016",
month = "4",
day = "1",
language = "English",
volume = "43",
pages = "455--457",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - A case of virchow's lymph node recurrence of gastric cancer who had underwent gastrectomy, and treated with S-1 monotherapy leading to complete response (CR)

AU - Tanaka, Shinichi

AU - Sanefuji, Kensaku

AU - Kabashima, Akira

AU - Maekawa, Souichirou

PY - 2016/4/1

Y1 - 2016/4/1

N2 - We report the case of a 67-year-old male with Virchow's lymph node recurrence of gastric cancer, who underwent distal gastrectomy for type 2 forecourt part of pylorus gastric cancer, showing complete response (CR) in response to S-1 monotherapy. The tumor was pathologically diagnosed as Stage IIIb (well to poorly differentiated adenocarcinoma, T3 [SE], N2 [20/51], MO). Virchow's lymph node metastasis was confirmed 2 months after surgery. One week after S-1 administration, a reduction in lymph node size was observed. After 5 courses of S-1 monotherapy, he achieved CR. The patient maintained CR for 2 years, before we switched to uracil and tegaf ur (UFT) monotherapy. The patient maintained CR for 2 years, after which UFT was discontinued. No relapse was observed 22 months after discontinuation.

AB - We report the case of a 67-year-old male with Virchow's lymph node recurrence of gastric cancer, who underwent distal gastrectomy for type 2 forecourt part of pylorus gastric cancer, showing complete response (CR) in response to S-1 monotherapy. The tumor was pathologically diagnosed as Stage IIIb (well to poorly differentiated adenocarcinoma, T3 [SE], N2 [20/51], MO). Virchow's lymph node metastasis was confirmed 2 months after surgery. One week after S-1 administration, a reduction in lymph node size was observed. After 5 courses of S-1 monotherapy, he achieved CR. The patient maintained CR for 2 years, before we switched to uracil and tegaf ur (UFT) monotherapy. The patient maintained CR for 2 years, after which UFT was discontinued. No relapse was observed 22 months after discontinuation.

UR - http://www.scopus.com/inward/record.url?scp=84973863221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973863221&partnerID=8YFLogxK

M3 - Article

C2 - 27220793

AN - SCOPUS:84973863221

VL - 43

SP - 455

EP - 457

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 4

ER -